155 related articles for article (PubMed ID: 10902780)
1. Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters.
Pohlenz J; Duprez L; Weiss RE; Vassart G; Refetoff S; Costagliola S
J Clin Endocrinol Metab; 2000 Jul; 85(7):2366-9. PubMed ID: 10902780
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidism.
Pohlenz J; Refetoff S
Biochimie; 1999 May; 81(5):469-76. PubMed ID: 10403177
[TBL] [Abstract][Full Text] [Related]
4. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa.
Spitzweg C; Joba W; Eisenmenger W; Heufelder AE
J Clin Endocrinol Metab; 1998 May; 83(5):1746-51. PubMed ID: 9589686
[TBL] [Abstract][Full Text] [Related]
5. The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.
De La Vieja A; Ginter CS; Carrasco N
J Cell Sci; 2004 Feb; 117(Pt 5):677-87. PubMed ID: 14734652
[TBL] [Abstract][Full Text] [Related]
6. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.
Ajjan RA; Kemp EH; Waterman EA; Watson PF; Endo T; Onaya T; Weetman AP
J Clin Endocrinol Metab; 2000 May; 85(5):2020-7. PubMed ID: 10843191
[TBL] [Abstract][Full Text] [Related]
7. Expression of the sodium iodide symporter in human kidney.
Spitzweg C; Dutton CM; Castro MR; Bergert ER; Goellner JR; Heufelder AE; Morris JC
Kidney Int; 2001 Mar; 59(3):1013-23. PubMed ID: 11231356
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer.
Castro MR; Bergert ER; Beito TG; Roche PC; Ziesmer SC; Jhiang SM; Goellner JR; Morris JC
J Endocrinol; 1999 Dec; 163(3):495-504. PubMed ID: 10588823
[TBL] [Abstract][Full Text] [Related]
9. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line.
Smit JW; Shröder-van der Elst JP; Karperien M; Que I; van der Pluijm G; Goslings B; Romijn JA; van der Heide D
Thyroid; 2000 Nov; 10(11):939-43. PubMed ID: 11128720
[TBL] [Abstract][Full Text] [Related]
10. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
[TBL] [Abstract][Full Text] [Related]
11. Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients.
Kosugi S; Inoue S; Matsuda A; Jhiang SM
J Clin Endocrinol Metab; 1998 Sep; 83(9):3373-6. PubMed ID: 9745458
[TBL] [Abstract][Full Text] [Related]
12. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
13. Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells.
Castro MR; Bergert ER; Beito TG; McIver B; Goellner JR; Morris JC
J Clin Endocrinol Metab; 1999 Aug; 84(8):2957-62. PubMed ID: 10443704
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in the sodium/iodide symporter gene in the largest family with iodide transport defect.
Kosugi S; Bhayana S; Dean HJ
J Clin Endocrinol Metab; 1999 Sep; 84(9):3248-53. PubMed ID: 10487695
[TBL] [Abstract][Full Text] [Related]
15. Hypothyroidism in a Brazilian kindred due to iodide trapping defect caused by a homozygous mutation in the sodium/iodide symporter gene.
Pohlenz J; Medeiros-Neto G; Gross JL; Silveiro SP; Knobel M; Refetoff S
Biochem Biophys Res Commun; 1997 Nov; 240(2):488-91. PubMed ID: 9388506
[TBL] [Abstract][Full Text] [Related]
16. Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions.
Covitz KM; Amidon GL; Sadée W
Biochemistry; 1998 Oct; 37(43):15214-21. PubMed ID: 9790685
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease.
Seissler J; Wagner S; Schott M; Lettmann M; Feldkamp J; Scherbaum WA; Morgenthaler NG
J Clin Endocrinol Metab; 2000 Dec; 85(12):4630-4. PubMed ID: 11134119
[TBL] [Abstract][Full Text] [Related]
18. Promoter characterization of the human Na+/I- symporter.
Ryu KY; Tong Q; Jhiang SM
J Clin Endocrinol Metab; 1998 Sep; 83(9):3247-51. PubMed ID: 9745437
[TBL] [Abstract][Full Text] [Related]
19. Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking.
Kim YH; Lee DS; Kang JH; Lee YJ; Chung JK; Roh JK; Kim SU; Lee MC
J Nucl Med; 2005 Feb; 46(2):305-11. PubMed ID: 15695791
[TBL] [Abstract][Full Text] [Related]
20. A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect.
Matsuda A; Kosugi S
J Clin Endocrinol Metab; 1997 Dec; 82(12):3966-71. PubMed ID: 9398697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]